Duong Huong Thi, Moles Jean-Pierre, Pham Khue Minh, Vallo Roselyne, Hoang Giang Thi, Vu Vinh Hai, Khuat Oanh Thi Hai, Nham Thanh Tuyet Thi, Nguyen Duc Quang, Quillet Catherine, Rapoud Delphine, Van de Perre Philippe, Castellani Joëlle, Feelemyer Jonathan, Michel Laurent, Laureillard Didier, Jarlais Don Des, Nagot Nicolas
Department of Public Health, Haiphong University of Medicine and Pharmacy, Số 72A Nguyễn Bỉnh Khiêm, Ngô Quyền, Haiphong, Vietnam.
Pathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, 60 Rue de Navacelles, 34394 Montpellier, France.
Lancet Reg Health West Pac. 2022 Jul 11;27:100538. doi: 10.1016/j.lanwpc.2022.100538. eCollection 2022 Oct.
In most low-to-middle-income countries, HIV control at the population level among people who inject drugs (PWID) remains a major challenge. We aimed to demonstrate that an innovative intervention can identify HIV-positive PWID in the community who are not treated efficiently, and get them treated efficiently.
Between 2016 and 2020, we implemented an intervention consisting of mass HIV screening of PWID using three annual respondent-driven sampling surveys (RDSS) and a post-intervention evaluation RDSS in community-based organisation (CBO) sites, coupled with peer support to facilitate/improve access to antiretroviral and methadone therapy in Haiphong, Vietnam. The primary outcome was the proportion of identified uncontrolled HIV-positive PWID who achieved viral control. We also estimated the potential effect of the intervention on the proportion of PWID with HIV RNA >1000 copies/mL among all PWID during the study period.
Over the three RDSS, 3150 different PWID were screened, i.e. two-thirds of the estimated population size. They all injected heroin, their median age was of 39 years, 95% were male, 26.5% were HIV-infected, and 78.6% of the latter had HIV RNA ≤1000 copies/mL. Among the 177 PWID identified with an unsuppressed viral load, 73 (41.2%) achieved viral suppression at the final visit. HIV viremia decreased from 7.2% at baseline to 2.9% at the final RDSS (<0.001). Up to 42% of this observed reduction may be explained by the intervention, in the absence of any external intervention targeting PWID during the study period.
Mass community-based screening using RDSS coupled with CBO support is a powerful tool to rapidly identify untreated HIV-positive PWID and (re)link them to care.
NIDA (USA) and ANRS (France).
在大多数中低收入国家,在注射吸毒者群体中进行艾滋病毒控制仍然是一项重大挑战。我们旨在证明一种创新干预措施能够识别出社区中未得到有效治疗的艾滋病毒阳性注射吸毒者,并使他们得到有效治疗。
2016年至2020年期间,我们实施了一项干预措施,在越南海防市的社区组织场所进行了三次年度应答者驱动抽样调查(RDSS),对注射吸毒者进行大规模艾滋病毒筛查,并在干预后进行评估RDSS,同时提供同伴支持,以促进/改善获得抗逆转录病毒疗法和美沙酮治疗的机会。主要结果是已识别的未得到控制的艾滋病毒阳性注射吸毒者实现病毒控制的比例。我们还估计了该干预措施对研究期间所有注射吸毒者中艾滋病毒RNA>1000拷贝/毫升的注射吸毒者比例的潜在影响。
在三次RDSS中,共筛查了3150名不同的注射吸毒者,即估计人口规模的三分之二。他们都注射海洛因,年龄中位数为39岁,95%为男性,26.5%感染艾滋病毒,其中78.6%的艾滋病毒RNA≤1000拷贝/毫升。在177名病毒载量未得到抑制的注射吸毒者中,73名(41.2%)在最后一次随访时实现了病毒抑制。艾滋病毒病毒血症从基线时的7.2%降至最后一次RDSS时的2.9%(<0.001)。在研究期间没有针对注射吸毒者的任何外部干预的情况下,观察到的这种减少中高达42%可能归因于该干预措施。
使用RDSS并结合社区组织支持进行大规模社区筛查是一种快速识别未接受治疗的艾滋病毒阳性注射吸毒者并使其重新获得治疗的有力工具。
美国国立药物滥用研究所(NIDA)和法国国家艾滋病研究机构(ANRS)。